Previous close | 4.7000 |
Open | 2.8500 |
Bid | 1.9500 |
Ask | 3.5000 |
Strike | 195.00 |
Expiry date | 2024-06-21 |
Day's range | 2.8500 - 3.2000 |
Contract range | N/A |
Volume | |
Open interest | 21 |
Total fiscal 2024 revenue increased 12% to $5.5 billionTotal fiscal 2024 U.S. GAAP earnings per diluted share of $3.81; adjusted earnings per diluted share increased to $8.83Targeted restructuring plan announced DUBLIN, IRELAND , May 08, 2024 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) today announced financial results for its fiscal 2024 fourth quarter ended March 31, 2024. Total revenue for the fourth quarter of fiscal 2024 increased 10% to $1.5 billion compared with
Shockwave Medical (SWAV) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Get a deeper insight into the potential performance of Steris (STE) for the quarter ended March 2024 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.